Stock Analysis

There May Be Underlying Issues With The Quality Of Shanghai Menon Animal Nutrition Technology's (SZSE:301156) Earnings

SZSE:301156
Source: Shutterstock

Shanghai Menon Animal Nutrition Technology Co., Ltd. (SZSE:301156) just reported some strong earnings, and the market reacted accordingly with a healthy uplift in the share price. However, our analysis suggests that shareholders may be missing some factors that indicate the earnings result was not as good as it looked.

Check out our latest analysis for Shanghai Menon Animal Nutrition Technology

earnings-and-revenue-history
SZSE:301156 Earnings and Revenue History May 1st 2024

How Do Unusual Items Influence Profit?

For anyone who wants to understand Shanghai Menon Animal Nutrition Technology's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit gained from CN„6.4m worth of unusual items. While it's always nice to have higher profit, a large contribution from unusual items sometimes dampens our enthusiasm. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And that's as you'd expect, given these boosts are described as 'unusual'. Assuming those unusual items don't show up again in the current year, we'd thus expect profit to be weaker next year (in the absence of business growth, that is).

Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of Shanghai Menon Animal Nutrition Technology.

Our Take On Shanghai Menon Animal Nutrition Technology's Profit Performance

We'd posit that Shanghai Menon Animal Nutrition Technology's statutory earnings aren't a clean read on ongoing productivity, due to the large unusual item. Therefore, it seems possible to us that Shanghai Menon Animal Nutrition Technology's true underlying earnings power is actually less than its statutory profit. But at least holders can take some solace from the 25% EPS growth in the last year. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. If you'd like to know more about Shanghai Menon Animal Nutrition Technology as a business, it's important to be aware of any risks it's facing. You'd be interested to know, that we found 2 warning signs for Shanghai Menon Animal Nutrition Technology and you'll want to know about these.

This note has only looked at a single factor that sheds light on the nature of Shanghai Menon Animal Nutrition Technology's profit. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.

Valuation is complex, but we're helping make it simple.

Find out whether Shanghai Menon Animal Nutrition Technology is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.